DK0423326T3 - Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta - Google Patents

Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta

Info

Publication number
DK0423326T3
DK0423326T3 DK90908015T DK90908015T DK0423326T3 DK 0423326 T3 DK0423326 T3 DK 0423326T3 DK 90908015 T DK90908015 T DK 90908015T DK 90908015 T DK90908015 T DK 90908015T DK 0423326 T3 DK0423326 T3 DK 0423326T3
Authority
DK
Denmark
Prior art keywords
peptide
calcium metabolism
pct
physiologically active
hitherto unknown
Prior art date
Application number
DK90908015T
Other languages
Danish (da)
English (en)
Inventor
Ronald C Orlowski
Satoshi Hanamura
Masahiko Marumoto
Kenji Sakamoto
Yoshihiro Waki
Original Assignee
Tsumura & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsumura & Co filed Critical Tsumura & Co
Application granted granted Critical
Publication of DK0423326T3 publication Critical patent/DK0423326T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/585—Calcitonins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Genetics & Genomics (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Zoology (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK90908015T 1989-04-21 1990-04-19 Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta DK0423326T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US34180089A 1989-04-21 1989-04-21
US43735089A 1989-11-16 1989-11-16
PCT/US1990/002143 WO1990012809A1 (en) 1989-04-21 1990-04-19 Novel physiologically active peptide and calcium metabolism-regulating agent comprising said peptide as effective ingredient

Publications (1)

Publication Number Publication Date
DK0423326T3 true DK0423326T3 (da) 1999-05-25

Family

ID=26992670

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90908015T DK0423326T3 (da) 1989-04-21 1990-04-19 Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta

Country Status (12)

Country Link
US (1) US6127519A (ko)
EP (1) EP0423326B1 (ko)
JP (1) JP2778249B2 (ko)
KR (1) KR0141973B1 (ko)
AT (1) ATE170191T1 (ko)
AU (1) AU640141B2 (ko)
BR (1) BR9006746A (ko)
CA (1) CA2030795C (ko)
DE (1) DE69032591T2 (ko)
DK (1) DK0423326T3 (ko)
ES (1) ES2119746T3 (ko)
WO (1) WO1990012809A1 (ko)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364840A (en) * 1989-12-05 1994-11-15 Vical, Inc. Synthetic calcitonin peptides
ES2055665B1 (es) * 1993-02-03 1995-03-01 Lipotec Sa Procedimiento para la obtencion de carbocalcitonina.

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH550774A (de) * 1968-10-15 1974-06-28 Ciba Geigy Ag Verfahren zur herstellung neuer hypocalcaemischer peptide.
CH523868A (de) * 1969-10-22 1972-06-15 Ciba Geigy Ag Verfahren zur Herstellung neuer Dotriacontapeptidamide und ihrer Derivate
AR207116A1 (es) * 1973-03-28 1976-09-15 Ciba Geigy Ag Procedimiento para preparar nuevas dotriacontapeptidoamidas
JPS51128993A (en) * 1975-05-01 1976-11-10 Tanpakushitsu Kenkyu Shiyoureikai Process for preparing new polypeptides
US4212795A (en) * 1978-11-13 1980-07-15 Armour Pharmaceutical Company Cyclization of peptides
US4663309A (en) * 1983-06-29 1987-05-05 University Patents, Inc. Novel peptide hormones with calcitonin-like activity
US4497732A (en) * 1983-10-21 1985-02-05 Armour Pharmaceutical Company 1A-Endo-glycine-calcitonin
US4604237A (en) * 1984-11-20 1986-08-05 Armour Pharmaceutical Company Des-21-threonine-calcitonin
US4606856A (en) * 1985-03-18 1986-08-19 Seyler Jay K [Des-1-amino, 8-glycine]calcitonin
US4622386A (en) * 1985-03-28 1986-11-11 Armour Pharmaceutical Company [1,7-di-alanine]calcitonin
US4644054A (en) * 1985-10-01 1987-02-17 Kempe Tomas G Calcitonin analogs with amino acid substituents at position 31
NL8602950A (nl) * 1985-12-04 1987-07-01 Sandoz Ag Calcitonine-derivaten en werkwijzen voor het bereiden van deze derivaten en van farmaceutische preparaten die ze bevatten.
US4658014A (en) * 1985-12-20 1987-04-14 Kempe Tomas G Synthetic peptides with calcitonin-like activity
US4746728A (en) * 1986-05-05 1988-05-24 Armour Pharmaceutical Company 8-glycine, des-19-leucine-calcitonin
US4732969A (en) * 1986-05-05 1988-03-22 Armour Pharmaceutical Corporation Des-19-leucine, 20-glutamine-calcitonin
US4820804A (en) * 1987-04-21 1989-04-11 Rorer Pharmaceutical Corporation Analogs of [1,7-di-alanine, des-19-leucine]calcitonin
US4764590A (en) * 1987-04-21 1988-08-16 Rorer Pharmaceutical Corporation Des-19-leucine, 20-glutamine, 21-threonine-calcitonin
US4764591A (en) * 1987-04-21 1988-08-16 Rorer Pharmaceutical Corporation Des-19-leucine, 20-glutamine, 21-threonine, 22-tyrosine-calcitonin
US4764589A (en) * 1987-05-26 1988-08-16 Rorer Pharmaceutical Corporation [N-alpha-acyl,8-glycine, des-19-leucine]-calcitonin
AU609911B2 (en) * 1987-12-16 1991-05-09 Rorer International (Overseas) Inc. 8-glycine,16-x, des-19-leucine-calcitonin
JPH02262595A (ja) * 1988-02-29 1990-10-25 Otsuka Pharmaceut Co Ltd ポリペプチド誘導体

Also Published As

Publication number Publication date
BR9006746A (pt) 1991-08-06
EP0423326B1 (en) 1998-08-26
AU640141B2 (en) 1993-08-19
KR0141973B1 (ko) 1998-06-15
ATE170191T1 (de) 1998-09-15
DE69032591D1 (de) 1998-10-01
CA2030795A1 (en) 1990-10-22
JPH03505589A (ja) 1991-12-05
AU5548790A (en) 1990-11-16
EP0423326A1 (en) 1991-04-24
DE69032591T2 (de) 1999-01-07
US6127519A (en) 2000-10-03
ES2119746T3 (es) 1998-10-16
CA2030795C (en) 1999-11-30
WO1990012809A1 (en) 1990-11-01
KR920700224A (ko) 1992-02-19
JP2778249B2 (ja) 1998-07-23

Similar Documents

Publication Publication Date Title
DE3585556D1 (de) Pharmazeutische zusammensetzungen, welche ein dipeptid enthalten.
FI860153A0 (fi) Oligopeptider, deras mellanprodukter och foerfarande foer deras framstaellning.
HUP0100928A2 (hu) Humán inzulin B láncának részletét tartalmazó peptidanalógok, ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
BR9710452A (pt) Anïïlogos de exendina processos para sua prepara-Æo e medicamentos contendo os mesmos
MX9703643A (es) Metodos para tratamiento de esclerosis multiple usando analogos de peptidos de proteina basica de mielina humana.
DK159856C (da) Humaninsulinderivater og farmaceutiske praeparater, som indeholder disse derivater
DK0479948T3 (da) Sammensætninger og fremgangsmåder til syntese af natriuretisk protein-receptor B og anvendelsesfremgangsmåder
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
RU94036776A (ru) Домен ингибитора протеазы, днк, вектор, клетка, способ получения ингибитора протеазы, фармацевтическая композиция, применение домена ингибитора протеазы
MX9703642A (es) Metodos para el tratamiento de esclerosis multiple utilizando analogos de peptido en la posicion 91 de la proteina basica de mielina humana.
IS1966B (is) Peptíð p277 hliðstæður og lyfjasamsetningar sem innihalda þær, til meðhöndlunar eða sjúkdómsgreiningar á sykursýki
DK482185A (da) Peptider, deres fremstilling og anvendelse som laegemidler
MY103251A (en) Biologically active molecules
EP0264953A3 (en) Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use
EP0561877A4 (ko)
DK0423326T3 (da) Hidtil ukendt fysiologisk aktivt peptid og calcium-metabolisme-regulerende middel, der omfatter peptidet som effektiv besta
EP0490383A3 (en) Peptides of the hiv-gag protein, their preparation and use
AU637589B2 (en) Ancrod proteins, their production and use
DE3162674D1 (en) A purified polypeptide, a process for its preparation, its use and pharmaceutical compositions containing it